ibogaine has been researched along with dynorphins in 2 studies
Studies (ibogaine) | Trials (ibogaine) | Recent Studies (post-2010) (ibogaine) | Studies (dynorphins) | Trials (dynorphins) | Recent Studies (post-2010) (dynorphins) |
---|---|---|---|---|---|
445 | 8 | 136 | 3,096 | 24 | 514 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alburges, ME; Hanson, GR | 1 |
Fishback, J; Garamszegi, N; Heghinian, MD; Maillet, EL; Mash, DC; Milon, N; Schürer, SC | 1 |
2 other study(ies) available for ibogaine and dynorphins
Article | Year |
---|---|
Ibogaine pretreatment dramatically enhances the dynorphin response to cocaine.
Topics: Animals; Brain Chemistry; Cocaine; Dopamine Uptake Inhibitors; Dynorphins; Excitatory Amino Acid Antagonists; Ibogaine; Male; Neostriatum; Neural Pathways; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Substantia Nigra | 1999 |
Noribogaine is a G-protein biased κ-opioid receptor agonist.
Topics: Analgesics, Opioid; Animals; Arrestins; beta-Arrestins; CHO Cells; Computer Simulation; Cricetulus; Drug Evaluation, Preclinical; Dynorphins; GTP-Binding Proteins; Humans; Ibogaine; Mesencephalon; Mice; Models, Molecular; Morphinans; Rats; Receptors, Opioid, kappa; Receptors, Opioid, mu; Signal Transduction; Substance-Related Disorders | 2015 |